Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021

SELL
$85.24 - $94.15 $208,326 - $230,102
-2,444 Closed
0 $0
Q1 2021

May 04, 2021

SELL
$83.5 - $98.47 $3,674 - $4,332
-44 Reduced 1.77%
2,444 $209,000
Q3 2020

Nov 02, 2020

SELL
$82.14 - $91.0 $83,700 - $92,729
-1,019 Reduced 29.06%
2,488 $216,000
Q2 2020

Jul 31, 2020

BUY
$80.93 - $91.1 $283,821 - $319,487
3,507 New
3,507 $306,000
Q4 2019

Jan 29, 2020

SELL
$84.35 - $95.37 $364,138 - $411,712
-4,317 Closed
0 $0
Q3 2019

Oct 31, 2019

BUY
$85.54 - $94.26 $369,276 - $406,920
4,317 New
4,317 $375,000
Q4 2018

Feb 06, 2019

SELL
$73.66 - $82.02 $279,171 - $310,855
-3,790 Closed
0 $0
Q3 2018

Oct 09, 2018

BUY
$66.94 - $77.43 $13,321 - $15,408
199 Added 5.54%
3,790 $327,000
Q2 2018

Aug 01, 2018

SELL
$64.91 - $73.36 $13,241 - $14,965
-204 Reduced 5.38%
3,591 $271,000
Q1 2018

May 15, 2018

SELL
$70.39 - $84.15 $22,172 - $26,507
-315 Reduced 7.66%
3,795 $307,000
Q4 2017

May 15, 2018

SELL
$72.33 - $77.64 $4,339 - $4,658
-60 Reduced 1.44%
4,110 $345,000
Q4 2017

Feb 01, 2018

BUY
$72.33 - $77.64 $301,616 - $323,758
4,170
4,170 $350,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Kovack Advisors, Inc. Portfolio

Follow Kovack Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.